116 related articles for article (PubMed ID: 23786457)
1. Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia.
Le Jeune C; Bertoli S; Elhamri M; Vergez F; Borel C; Huguet F; Michallet M; Dumontet C; Recher C; Thomas X
Leuk Lymphoma; 2014 Apr; 55(4):855-62. PubMed ID: 23786457
[TBL] [Abstract][Full Text] [Related]
2. Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission.
Bar M; Othus M; Park HM; Sandhu V; Chen X; Wood BL; Estey E
Leuk Lymphoma; 2015; 56(11):3109-15. PubMed ID: 25726954
[TBL] [Abstract][Full Text] [Related]
3. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.
Behl D; Porrata LF; Markovic SN; Letendre L; Pruthi RK; Hook CC; Tefferi A; Elliot MA; Kaufmann SH; Mesa RA; Litzow MR
Leukemia; 2006 Jan; 20(1):29-34. PubMed ID: 16281063
[TBL] [Abstract][Full Text] [Related]
4. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
De Angulo G; Yuen C; Palla SL; Anderson PM; Zweidler-McKay PA
Cancer; 2008 Jan; 112(2):407-15. PubMed ID: 18058809
[TBL] [Abstract][Full Text] [Related]
5. Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts.
Michelis FV; Messner HA; Loach D; Uhm J; Gupta V; Lipton JH; Seftel MD; Kuruvilla J; Kim DD
Eur J Haematol; 2014 Oct; 93(4):273-80. PubMed ID: 24725056
[TBL] [Abstract][Full Text] [Related]
6. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.
Jahic A; Iljazovic E; Hasic S; Arnautovic AC; Sabitovic D; Mesanovic S; Sahovic H; Simendic V
Med Arch; 2017 Feb; 71(1):20-24. PubMed ID: 28428668
[TBL] [Abstract][Full Text] [Related]
8. Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
Sun D; Elson P; Liedtke M; Medeiros BC; Earl M; Alizadeh A; Bates J; Sekeres MA; Coutre S; Kalaycio M; Sobecks R; Copelan E; Advani AS
Am J Hematol; 2012 Oct; 87(10):957-60. PubMed ID: 22729847
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
[TBL] [Abstract][Full Text] [Related]
10. Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia.
Zhang Y; Gu H; Chen Q; Zhang Y; Cheng H; Yang J; Wang J; Hu X
Acta Haematol; 2020; 143(1):9-18. PubMed ID: 31167182
[TBL] [Abstract][Full Text] [Related]
11. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
Chen X; Xie H; Wood BL; Walter RB; Pagel JM; Becker PS; Sandhu VK; Abkowitz JL; Appelbaum FR; Estey EH
J Clin Oncol; 2015 Apr; 33(11):1258-64. PubMed ID: 25732155
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
[TBL] [Abstract][Full Text] [Related]
13. Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.
Farkas T; Müller J; Erdelyi DJ; Csoka M; Kovacs GT
Pathol Oncol Res; 2017 Oct; 23(4):889-897. PubMed ID: 28138921
[TBL] [Abstract][Full Text] [Related]
14. Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.
Choi YW; Jeong SH; Ahn MS; Lee HW; Kang SY; Choi JH; Park JS
J Korean Med Sci; 2015 Oct; 30(10):1416-22. PubMed ID: 26425037
[TBL] [Abstract][Full Text] [Related]
15. [Lymphocyte Count before First Consolidation Therapy Is A Predictor of Relapse free Survival in Acute Myeloid Leukemia].
Pang YB; Fan LX; Tian MJ; Zhao SY; Hua LM; Luo JM; DU X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):993-998. PubMed ID: 30111396
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
Ornstein MC; Mukherjee S; Mohan S; Elson P; Tiu RV; Saunthararajah Y; Kendeigh C; Advani A; Kalaycio M; Maciejewski JP; Sekeres MA
Am J Hematol; 2014 Feb; 89(2):168-73. PubMed ID: 24123154
[TBL] [Abstract][Full Text] [Related]
17. High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia.
Mabuchi R; Hara T; Matsumoto T; Shibata Y; Nakamura N; Nakamura H; Kitagawa J; Kanemura N; Goto N; Shimizu M; Ito H; Yamamoto Y; Saito K; Moriwaki H; Tsurumi H
Leuk Lymphoma; 2016; 57(1):92-8. PubMed ID: 25907424
[TBL] [Abstract][Full Text] [Related]
18. Normal Absolute Monocyte Count in Combination with Normal/High Absolute Lymphocyte Count at the Time of Relapse is Associated with Improved Survival in Patients with Early Relapsed Acute Myeloid Leukemia.
Zhang Y; Dai K; Zhang Q; Huang Y; Feng Y; Bhardwaj D; Yu K; Feng J
Cancer Invest; 2021; 39(6-7):550-558. PubMed ID: 34027748
[TBL] [Abstract][Full Text] [Related]
19. Absolute Monocyte Count is Superior than Absolute Lymphocyte Count at Day 28 as an Independent Prognostic Factor in Acute Myeloid Leukemia.
Ismail MM; Abdulateef NAB
Indian J Hematol Blood Transfus; 2019 Jan; 35(1):100-108. PubMed ID: 30828155
[TBL] [Abstract][Full Text] [Related]
20. Effect of initial absolute monocyte count on survival outcome of patients with de novo non-M3 acute myeloid leukemia.
Feng J; Zhang W; Wu J; Gao S; Ye H; Sun L; Chen Y; Yu K; Xing CY
Leuk Lymphoma; 2016 Nov; 57(11):2548-54. PubMed ID: 27074049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
